Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials
Titel:
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials
Auteur:
Clotet, Bonaventura Bellos, Nicholas Molina, Jean-Michel Cooper, David Goffard, Jean-Christophe Lazzarin, Adriano Wöhrmann, Andrej Katlama, Christine Wilkin, Timothy Haubrich, Richard Cohen, Calvin Farthing, Charles Jayaweera, Dushyantha Markowitz, Martin Ruane, Peter Spinosa-Guzman, Sabrina Lefebvre, Eric